Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
you are here: HomeNewsVivimedlabs
stock views
Jump to
23 Results Found
  • Bull's Eye: Buy Jet Airways, L&T Finance, NIIT Tech, Strides Shasun, Indiabulls Real Estate Dec 21, 2017 08:08 AM IST

    Bull's Eye: Buy Jet Airways, L&T Finance, NIIT Tech, Strides Shasun, Indiabulls Real Estate

    Vishal Malkan of malkansview.com recommends buying L&T Finance Holdings with a stoploss at Rs 165 and target of Rs 185 and a buy also on Tata Motors DVR with a stoploss at Rs 225 and target of Rs 245.

  • Bull's Eye: Buy Delta Corp, IRB Infra, Bata, Jet Airways, DHFL; Sell Exide Dec 18, 2017 08:01 AM IST

    Bull's Eye: Buy Delta Corp, IRB Infra, Bata, Jet Airways, DHFL; Sell Exide

    Vishal Malkan of malkansview.com advises buying Bata India with a target of Rs 765.

  • Buy Reliance Industries, Indraprastha Gas, HDFC Bank, Avanti Feeds: Ashwani Gujral Oct 10, 2017 12:57 PM IST

    Buy Reliance Industries, Indraprastha Gas, HDFC Bank, Avanti Feeds: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Reliance Industries, Indraprastha Gas, HDFC Bank and Avanti Feeds.

  • Bull's Eye: Buy Wockhardt, KPIT Tech, NMDC; sell JSW Energy, Apollo Tyres Sep 27, 2017 07:58 AM IST

    Bull's Eye: Buy Wockhardt, KPIT Tech, NMDC; sell JSW Energy, Apollo Tyres

    Vijay Chopra of enochventures.com is of the view that one may buy NMDC with a target of Rs 130.

  • Bull's Eye: Buy Tata Motors, Godrej Properties, Nucleus Software; sell Adani Enterprises Sep 25, 2017 08:06 AM IST

    Bull's Eye: Buy Tata Motors, Godrej Properties, Nucleus Software; sell Adani Enterprises

    Vijay Chopra of enochventures.com advices buying Oil India with a target of Rs 335.

  • Ashish Kacholia: This multibagger smallcap picker has 19 stock ideas to win big Aug 03, 2017 08:23 AM IST

    Ashish Kacholia: This multibagger smallcap picker has 19 stock ideas to win big

    The approach of investing towards small to midcap in a scenario where the market is trading at record highs should be based on core fundamentals and not momentum in the stocks.

  • Here are SP Tulsian's top trading picks May 25, 2017 03:40 PM IST

    Here are SP Tulsian's top trading picks

    In an interview to CNBC-TV18's Surabhi Upadhyay and Reema Tendulkar, SP Tulsian shared his outlook and readings on the fundamentals of the market and specific stocks.

  • Thomas Cook showing signs of improvement: Deven Choksey Feb 15, 2017 09:33 AM IST

    Thomas Cook showing signs of improvement: Deven Choksey

    In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers shared his readings and outlook on specific stocks that came out with good quarterly numbers.

  • Tulsian's take on ICICI Pru Life listing, MRF & other tyre shrs Sep 28, 2016 06:59 PM IST

    Tulsian's take on ICICI Pru Life listing, MRF & other tyre shrs

    SP Tulsian of sptulsian.com tells CNBC-TV18 why he would not give a buy call on MRF stock which touched Rs 50,000-mark in trade Wednesday. He also shares his take on other tyre stocks.

  • Here are a few investment ideas from SP Tulsian Sep 28, 2016 09:25 AM IST

    Here are a few investment ideas from SP Tulsian

    In an interview to CNBC-TV18's Latha Venkatesh and Anuj Singhal, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.

  • Here are a few stocks to keep an eye on September 28 Sep 28, 2016 08:48 AM IST

    Here are a few stocks to keep an eye on September 28

    Here are a few stocks picked up by CNBC-TV18's analysts to focus today - stocks expected to gain are IGL, Vivimed Labs, Balaji Telefilms, ARSS infra, Motherson Sumi, Aurobindo Pharma, MPhasis and Tata Global Beverages while stocks expected to be under pressure are REC, Manpasand Beverages, Ahluwalia Contracts and Bajaj Finserv.

  • Vivimed Labs may test Rs 500 in 6 months, says SP Tulsian Jan 18, 2016 11:18 AM IST

    Vivimed Labs may test Rs 500 in 6 months, says SP Tulsian

    SP Tulsian of sptulsian.com is of the view that Vivimed Labs may test Rs 500 in next six months.

  • Short Jindal Steel; buy Lupin, Vivimed Labs: Pankaj Jain Sep 17, 2014 12:05 PM IST

    Short Jindal Steel; buy Lupin, Vivimed Labs: Pankaj Jain

    Pankaj Jain of Sunteck Wealthmax recommends going long in Vivimed Labs and Lupin.

  • Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital Sep 17, 2014 08:56 AM IST

    Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital

    Meghana V Malkan, malkansview.com advises buying Ranbaxy Labs for a target price of Rs 615 and selling Reliance Capital for a target price of Rs 495.

  • Buy GSFC, Onmobile Global, Vivimed Labs: Pankaj Jain Sep 16, 2014 01:58 PM IST

    Buy GSFC, Onmobile Global, Vivimed Labs: Pankaj Jain

    Pankaj Jain of Sunteck Wealthmax recommends buying DCB Bank and Vivimed Labs.

  • Bull's Eye: Buy DCB Bank, Eros International, CESC, UPL Sep 16, 2014 08:55 AM IST

    Bull's Eye: Buy DCB Bank, Eros International, CESC, UPL

    AK Prabhakar, Independent Advisor advises buying Eros International for a target price of Rs 300 and Bank of India for a target price of Rs 319.

  • Buy Vivimed Labs, Pennar Ind; short JP Asso: Pankaj Jain Sep 15, 2014 02:00 PM IST

    Buy Vivimed Labs, Pennar Ind; short JP Asso: Pankaj Jain

    Pankaj Jain of Sunteck Wealthmax recommends selling Indiabulls Real Estate and Jaiprakash Associates.

  • Bull's Eye: Buy Vivimed Labs, Tata Coffee, Exide Industries Sep 15, 2014 08:39 AM IST

    Bull's Eye: Buy Vivimed Labs, Tata Coffee, Exide Industries

    Pankaj Jain, Sunteck Wealthmax advises buying Vivimed Labs for a target price of Rs 375 and Pennar Industries for a target price of Rs 63.

  • Vivimed Labs may touch Rs 600: Sudip Bandyopadhyay May 25, 2012 03:59 PM IST

    Vivimed Labs may touch Rs 600: Sudip Bandyopadhyay

    Vivimed Labs may touch Rs 600, says Sudip Bandyopadhyay, MD & CEO, Destimoney Securities.

  • Bull's Eye: Buy Rel Power, Sun TV; short Crompton Greaves Feb 01, 2012 11:20 AM IST

    Bull's Eye: Buy Rel Power, Sun TV; short Crompton Greaves

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Vivimed Labs above Rs 260: Shardul Kulkarni Sep 28, 2011 12:44 PM IST

    Buy Vivimed Labs above Rs 260: Shardul Kulkarni

    Buy Vivimed Labs above Rs 260, says Shardul Kulkarni of Angel Broking.

  • Buy Vivimed Labs: Ashish Chugh Aug 18, 2011 01:12 PM IST

    Buy Vivimed Labs: Ashish Chugh

    Investment advisor Ashish Chugh feels that one should buy Vivimed Labs.

  • Vivimed Labs has target of Rs 400: SP Tulsian Jul 18, 2011 09:00 AM IST

    Vivimed Labs has target of Rs 400: SP Tulsian

    Vivimed Labs has target of Rs 400, says SP Tulsian of sptulsian.com.

Sections